Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheArticle : Périodique
J. S. MELO ; R. S. GARFEIN ; K. HAYASHI ; M. J. MILLOY ; K. DEBECK ; S. SUN ; S. JAIN ; S. A. STRATHDEE ; D. WERB |Background: The prevention of drug injecting is often cited as a justification for the deployment of law enforcement and for the continuation of drug criminalization policies. We sought to characterize the impact of law enforcement interactions [...]Article : Périodique
S. YOUNG ; E. WOOD ; M. J. MILLOY ; K. DEBECK ; S. DOBRER ; E. NOSOVA ; T. KERR ; K. HAYASHI |Background: People who inject drugs (PWID) have high rates of hepatitis C virus (HCV) infection. Little is known about the rates of diagnosis and treatment for HCV among PWID. Therefore, this study aims to characterize the cascade of care in Van[...]Article : Périodique
C. JOHNSON ; H. DONG ; K. AHAMAD ; K. HAYASHI ; M. J. MILLOY ; T. KERR ; E. WOOD |Introduction: While the impacts of illicit drug use on mortality have been well described, the impact of poly-substance that includes alcohol has received less attention. We examined the impact of binge alcohol use on mortality among a cohort of[...]Article : Périodique
L. WANG ; D. PANAGIOTOGLOU ; J. E. MIN ; K. DEBECK ; M. J. MILLOY ; T. KERR ; K. HAYASHI ; B. NOSYK |Background: People who inject drugs (PWID) face barriers to healthcare due to reasons including comorbidity. We evaluated access to health and social services by three of the most prevalent comorbid conditions among PWID: HIV, hepatitis C (HCV),[...]Article : Périodique
H. REDDON ; J. HO ; K. DEBECK ; M. J. MILLOY ; Y. LIU ; H. DONG ; K. AHAMAD ; E. WOOD ; T. KERR ; K. HAYASHI |Background and aim: Although methadone, an opioid agonist, has been an effective medication used to treat opioid use disorder for over 40 years, recent studies have found that methadone was identified in more than a quarter of prescription opioi[...]Article : Périodique
A. MAH ; M. W. HULL ; K. DEBECK ; M. J. MILLOY ; S. DOBRER ; E. NOSOVA ; E. WOOD ; T. KERR ; K. HAYASHI |Background: Knowledge of hepatitis C virus (HCV) is believed to be important in altering risk behaviour, improving engagement in care, and promoting willingness to initiate HCV treatment. We assessed factors associated with HCV knowledge and tre[...]Nouveauté
Article : Périodique
A. CAUDARELLA ; H. DONG ; M. J. MILLOY ; T. KERR ; E. WOOD ; K. HAYASHI |Objectives: To examine the relationship between non-fatal overdose and risk of subsequent fatal overdose. Methods: We assessed risk factors for overdose death among two prospective cohorts of persons who inject drugs (PWID) in Vancouver, Canada[...]Article : Périodique
K. DEBECK ; E. WOOD ; H. DONG ; S. DOBRER ; K. HAYASHI ; J. MONTANER ; T. KERR |The rapid increase of non-medical prescription opioid (PO) use among youth has been described as the most alarming drug use trend in North America (Compton and Volkow, 2006, McCabe et al., 2008 and Okie, 2010). After cannabis, youth consistently[...]Article : Périodique
G. R. WALTON ; K. HAYASHI ; P. BACH ; H. DONG ; T. KERR ; K. AHAMAD ; M. J. MILLOY ; J. MONTANER ; E. WOOD |OBJECTIVE: Illicit drug use is a well-established risk factor for increased morbidity and mortality. However, little is known about the impact of benzodiazepine use on mortality among populations of polysubstance users. This study aimed to ident[...]Article : Périodique
A. GADDIS ; M. C. KENNEDY ; E. NOSOVA ; M. J. MILLOY ; K. HAYASHI ; E. WOOD ; T. KERR |Objectives: Supervised injection facilities (SIFs) are increasingly being implemented worldwide in response to the harms associated with injection drug use. Although SIFs have been shown to promote engagement of people who use injection drugs (P[...]
